Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Breast Cancer Female × Radiofrequency Ablation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 17 Neoplasm Metastasis 11 Liver Neoplasms 8 Lung Neoplasms 6 Cholangiocarcinoma 6 Colorectal Neoplasms 5 Pancreatic Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Barrett Esophagus 4 Recurrence 3 Rectal Neoplasms 3 Pain 3 Colonic Neoplasms 3 Biliary Tract Neoplasms 3 Prostatic Neoplasms 2 Leiomyoma 2 Esophageal Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Thyroid Cancer, Papillary 1 Thymoma 1 Squamous Intraepithelial Lesions 1 Small Cell Lung Carcinoma 1 Pancreatic cancer, adult 1 Neuroendocrine Tumors 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Neoplasm Micrometastasis 1 Myoma 1 Mesothelioma, Malignant 1

Interventions

Exercise 3 Paclitaxel 2 Cyclophosphamide 2 Capecitabine 2 Bupivacaine 2 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 palbociclib 1 iniparib 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Thioctic Acid 1 Surveys and Questionnaires 1 Sodium Chloride 1 Ropivacaine 1 Radiofrequency Ablation 1 Neoadjuvant Therapy 1 Methotrexate 1 Metformin 1 Mastectomy 1 Electrochemotherapy 1 Educational Status 1 Drug Delivery Systems 1 Doxorubicin 1 Diet 1 Dexmedetomidine 1 Control Groups 1 Caloric Restriction 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04389216 2025-09-15

RFA

Hospital Universitari de Bellvitge

Phase NA Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡